Gilead Sciences (GILD) Other Operating Expenses (2009 - 2026)

Gilead Sciences (GILD) has reported Other Operating Expenses for 18 consecutive years, with $1.6 billion the latest figure, recorded in Q1 2026.

• Other Operating Expenses for Q1 2026 came in at $1.6 billion, down 13.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.6 billion (down 13.3% YoY), and the FY2025 annual result was $7.8 billion, down 48.01% from the prior year.
• Other Operating Expenses was $1.6 billion for Q1 2026 at Gilead Sciences, down from $2.6 billion in the prior quarter.
• Over five years, Other Operating Expenses peaked at $8.1 billion in Q1 2024 and troughed at $1.6 billion in Q1 2026.
• Average Other Operating Expenses over 5 years is $2.5 billion, with a median of $1.8 billion recorded in 2025.
• Year-over-year, Other Operating Expenses surged 331.31% in 2024 and tumbled 77.9% in 2025.
• Over 5 years, Other Operating Expenses stood at $3.2 billion in 2022, then fell by 21.53% to $2.5 billion in 2023, then plunged by 36.89% to $1.6 billion in 2024, then jumped by 63.35% to $2.6 billion in 2025, then plunged by 39.48% to $1.6 billion in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $1.6 billion in Q1 2026, $2.6 billion in Q4 2025, and $1.7 billion in Q3 2025.